NYSE · Financial Statements

Aspen Aerogels, Inc. (ASPN) Financial Statements

$5.52 NYSE: ASPN Market Cap $458.10M

Aspen Aerogels, Inc. most recently reported annual revenue of $271.0M, a net loss of $390.0M. Revenue grew at an average annual rate of 22.1% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Aspen Aerogels, Inc.: Revenue rose from $118.0M in 2016 to $271.0M in 2025, a change of +129.7% over 9 years; net profit was positive in 1 of 10 reported years; operating margin moved from -9.5% to -19.0%, a shift of -9.4 percentage points; the most recent year shows a net loss of $390.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$118.0M$112.0M$104.0M$139.0M$100.0M$122.0M$180.0M$239.0M$453.0M$271.0M
Operating Expenses$129.0M$131.0M$138.0M$154.0M$122.0M$162.0M$260.0M$288.0M$398.0M$322.0M
Operating Profit$-11.0M$-19.0M$-34.0M$-14.0M$-22.0M$-41.0M$-79.0M$-49.0M$55.0M$-51.0M
Operating Margin-9.5%-17.1%-32.5%-10.2%-21.5%-33.4%-43.9%-20.6%12.1%-19.0%
Other Income$-1.0M$0$-1.0M$0$0$4.0M$-3.0M$3.0M$-39.0M$-336.0M
Interest$0$0$1.0M$0$0$0$5.0M$5.0M$12.0M$6.1B
Depreciation$10.0M$11.0M$11.0M$10.0M$10.0M$9.0M$9.0M$18.0M$24.0M$45.0M
Profit Before Tax$-12.0M$-19.0M$-34.0M$-15.0M$-22.0M$-37.0M$-83.0M$-46.0M$15.0M$-387.0M
Tax$0$0$0$0$0$0$0$0$11.4M$-620,000
Net Profit$-12.0M$-19.0M$-34.0M$-15.0M$-22.0M$-37.0M$-83.0M$-46.0M$13.0M$-390.0M
EPS$-0.52$-0.83$-1.45$-0.20$-0.45$-1.22$-2.19$-0.66$0.17$-4.74
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$61.0M$84.0M$95.0M$118.0M$117.0M$123.0M$79.0M$78.0M$73.0M$41.0M$38.0M$50.0M
Operating Expenses$75.0M$83.0M$92.0M$98.0M$100.0M$108.0M$378.0M$83.0M$76.0M$-215.0M$58.0M$79.0M
Operating Profit$-15.0M$1.0M$2.0M$20.0M$17.0M$15.0M$-299.0M$-5.0M$-3.0M$256.0M$-20.0M$-29.0M
Operating Margin-24.1%1.6%2.6%17.0%14.8%11.9%-380.3%-6.6%-4.6%620.4%-53.9%-57.7%
Interest$2.0M$3.0M$4.0M$3.0M$3.0M$4.0M$2.0M$3.0M$3.0M$3.0M$3.0M$3.0M
Profit Before Tax$-13.0M$-1.0M$-1.0M$18.0M$-13.0M$11.0M$-300.0M$-8.0M$-6.0M$-73.0M$-24.0M$-23.0M
Tax$0$0$-70.1M$4.9M$-2.1M$-1.6M$-360,000$-10.0M$-10.3M$130,000$1.1M$-2.7M
Net Profit$-13.0M$-1.0M$-2.0M$17.0M$-13.0M$11.0M$-301.0M$-9.0M$-6.0M$-73.0M$-24.0M$-23.0M
EPS$-0.19$-0.01$-0.02$0.21$-0.17$0.14$-3.67$-0.11$-0.08$-0.88$-0.29$-0.28

Over the 10 years reported for Aspen Aerogels, Inc., cash stood at $157.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 3.90 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$135.0M$124.0M$99.0M$104.0M$97.0M$183.0M$643.0M$703.0M$895.0M$407.0M
Current Assets$50.0M$48.0M$37.0M$46.0M$47.0M$112.0M$370.0M$266.0M$409.0M$242.0M
Cash$18.0M$11.0M$3.0M$4.0M$16.0M$77.0M$281.0M$140.0M$221.0M$157.0M
Inventory$13.0M$9.0M$7.0M$9.0M$13.0M$12.0M$23.0M$39.0M$48.0M$38.0M
Receivables$18.0M$27.0M$26.0M$32.0M$16.0M$20.0M$57.0M$70.0M$109.0M$35.0M
Fixed Assets$84.0M$76.0M$62.0M$58.0M$50.0M$69.0M$271.0M$434.0M$480.0M$123.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$0$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0
Total Liabilities$19.0M$23.0M$29.0M$45.0M$30.0M$55.0M$196.0M$215.0M$280.0M$171.0M
Current Liabilities$18.0M$22.0M$23.0M$30.0M$14.0M$37.0M$79.0M$78.0M$110.0M$62.0M
Borrowings$0$4.0M$4.0M$8.0M$8.0M$15.0M$119.0M$139.0M$197.0M$144.0M
Other Liabilities$19.0M$19.0M$25.0M$36.0M$21.0M$39.0M$77.0M$76.0M$83.0M$27.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$116.0M$101.0M$70.0M$59.0M$68.0M$128.0M$447.0M$488.0M$615.0M$236.0M

For Aspen Aerogels, Inc., operating cash flow was positive in 2 of 10 reported years; free cash flow in the latest year was negative at $5.0M; free cash flow was positive in 0 of 10 years; financing activities used $1.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$-1.0M$-5.0M$-9.0M$-1.0M$-10.0M$-19.0M$-94.0M$-43.0M$46.0M$33.0M
Investing Cash Flow$-40.0M$-12.0M$-7.0M$-4.0M$-7.0M$-28.0M$-356.0M$-351.0M$-173.0M$-75.0M
Financing Cash Flow$-1.0M$-1.0M$4.0M$5.0M$1.0M$-2.0M$-13.0M$-1.0M$3.0M$-1.0M
Net Cash Flow$-15.0M$-7.0M$-7.0M$0$13.0M$60.0M$206.0M$-143.0M$81.0M$-63.0M
Free Cash Flow$-14.0M$-11.0M$-12.0M$-3.0M$-13.0M$-32.0M$-272.0M$-218.0M$-41.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.33
EV / EBITDA-5.96
FCF Yield7.96%
Quick Ratio2.24
Interest Coverage38.48
Return 1Y-36.69%
Return 3Y-34.68%
Return 5Y-83.94%

Aspen Aerogels, Inc. (ASPN) financials — frequently asked questions

What is Aspen Aerogels, Inc.'s annual revenue?

Aspen Aerogels, Inc. (ASPN) reported annual revenue of $271.0M in its most recent fiscal year.

What is Aspen Aerogels, Inc.'s net profit?

Aspen Aerogels, Inc. (ASPN) reported a net loss of $390.0M in its most recent fiscal year.

What is ASPN EV/EBITDA?

Aspen Aerogels, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -5.96. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Industrials StocksLow P/E Industrials StocksHigh Net Margin Industrials StocksDividend Industrials StocksLow Debt Industrials StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
ASPN Overview ASPN Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.